Global Induced Pluripotent Stem Cells (iPSCs) Market Growth (Status and Outlook) 2021-2026

  • receipt Report ID : 155754
  • calendar_today Published On: Feb, 2021
  • file_copy Pages: 115
  • list Pharmaceuticals and Healthcare
Buy @ $3660

According to this latest study, the 2020 growth of Induced Pluripotent Stem Cells (iPSCs) will have significant change from previous year. By the most conservative estimates of global Induced Pluripotent Stem Cells (iPSCs) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 79 million in 2019. Over the next five years the Induced Pluripotent Stem Cells (iPSCs) market will register a 12.7% CAGR in terms of revenue, the global market size will reach US$ 127.2 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Induced Pluripotent Stem Cells (iPSCs) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

Human iPSCs

Mouse iPSCs

Human iPSCs had a market share of 89.65% in 2019, followed by Mouse iPSCs.

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

Academic Research

Drug Development and Discovery

Toxicity Screening

Regenerative Medicine

Others

Academic Research is the largest segment of Induced Pluripotent Stem Cells (iPSCs) application,with a share of 32% in 2019.

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Fujifilm Holding Corporation (CDI)

Ncardia

Sumitomo Dainippon Pharma

Astellas Pharma Inc

Fate Therapeutics, Inc

Pluricell Biotech

Cell Inspire Biotechnology

ReproCELL

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size 2016-2026

2.1.2 Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Induced Pluripotent Stem Cells (iPSCs) Segment by Type

2.2.1 Human iPSCs

2.2.2 Human iPSCs

2.3 Induced Pluripotent Stem Cells (iPSCs) Market Size by Type

2.3.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Type

2.3.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2016-2021)

2.4 Induced Pluripotent Stem Cells (iPSCs) Segment by Application

2.4.1 Academic Research

2.4.2 Drug Development and Discovery

2.4.3 Toxicity Screening

2.4.4 Regenerative Medicine

2.4.5 Others

2.5 Induced Pluripotent Stem Cells (iPSCs) Market Size by Application

2.5.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Application

2.5.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2016-2021)

3 Global Induced Pluripotent Stem Cells (iPSCs) by Players

3.1 Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Players

3.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Players (2019-2021E)

3.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Players (2019-2021E)

3.2 Global Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Induced Pluripotent Stem Cells (iPSCs) by Regions

4.1 Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions (2016-2021)

4.2 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2016-2021)

4.3 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2016-2021)

4.4 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2016-2021)

4.5 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2016-2021)

5 Americas

5.1 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021)

5.2 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021)

5.3 Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2016-2021)

6.2 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021)

6.3 APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Induced Pluripotent Stem Cells (iPSCs) by Country (2016-2021)

7.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021)

7.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) by Region (2016-2021)

8.2 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021)

8.3 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Induced Pluripotent Stem Cells (iPSCs) Market Forecast

10.1 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Regions (2021-2026)

10.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Regions (2021-2026)

10.1.2 Americas Induced Pluripotent Stem Cells (iPSCs) Forecast

10.1.3 APAC Induced Pluripotent Stem Cells (iPSCs) Forecast

10.1.4 Europe Induced Pluripotent Stem Cells (iPSCs) Forecast

10.1.5 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Forecast

10.2 Americas Induced Pluripotent Stem Cells (iPSCs) Forecast by Countries (2021-2026)

10.2.1 United States Induced Pluripotent Stem Cells (iPSCs) Market Forecast

10.2.2 Canada Induced Pluripotent Stem Cells (iPSCs) Market Forecast

10.2.3 Mexico Induced Pluripotent Stem Cells (iPSCs) Market Forecast

10.2.4 Brazil Induced Pluripotent Stem Cells (iPSCs) Market Forecast

10.3 APAC Induced Pluripotent Stem Cells (iPSCs) Forecast by Region (2021-2026)

10.3.1 China Induced Pluripotent Stem Cells (iPSCs) Market Forecast

10.3.2 Japan Induced Pluripotent Stem Cells (iPSCs) Market Forecast

10.3.3 Korea Induced Pluripotent Stem Cells (iPSCs) Market Forecast

10.3.4 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Forecast

10.3.5 India Induced Pluripotent Stem Cells (iPSCs) Market Forecast

10.3.6 Australia Induced Pluripotent Stem Cells (iPSCs) Market Forecast

10.4 Europe Induced Pluripotent Stem Cells (iPSCs) Forecast by Country (2021-2026)

10.4.1 Germany Induced Pluripotent Stem Cells (iPSCs) Market Forecast

10.4.2 France Induced Pluripotent Stem Cells (iPSCs) Market Forecast

10.4.3 UK Induced Pluripotent Stem Cells (iPSCs) Market Forecast

10.4.4 Italy Induced Pluripotent Stem Cells (iPSCs) Market Forecast

10.4.5 Russia Induced Pluripotent Stem Cells (iPSCs) Market Forecast

10.5 Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Forecast by Region (2021-2026)

10.5.1 Egypt Induced Pluripotent Stem Cells (iPSCs) Market Forecast

10.5.2 South Africa Induced Pluripotent Stem Cells (iPSCs) Market Forecast

10.5.3 Israel Induced Pluripotent Stem Cells (iPSCs) Market Forecast

10.5.4 Turkey Induced Pluripotent Stem Cells (iPSCs) Market Forecast

10.5.5 GCC Countries Induced Pluripotent Stem Cells (iPSCs) Market Forecast

10.6 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Type (2021-2026)

10.8 Global Induced Pluripotent Stem Cells (iPSCs) Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 Fujifilm Holding Corporation (CDI)

11.1.1 Fujifilm Holding Corporation (CDI) Company Information

11.1.2 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Offered

11.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 Fujifilm Holding Corporation (CDI) Main Business Overview

11.1.5 Fujifilm Holding Corporation (CDI) Latest Developments

11.2 Ncardia

11.2.1 Ncardia Company Information

11.2.2 Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Offered

11.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Ncardia Main Business Overview

11.2.5 Ncardia Latest Developments

11.3 Sumitomo Dainippon Pharma

11.3.1 Sumitomo Dainippon Pharma Company Information

11.3.2 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Offered

11.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Sumitomo Dainippon Pharma Main Business Overview

11.3.5 Sumitomo Dainippon Pharma Latest Developments

11.4 Astellas Pharma Inc

11.4.1 Astellas Pharma Inc Company Information

11.4.2 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered

11.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 Astellas Pharma Inc Main Business Overview

11.4.5 Astellas Pharma Inc Latest Developments

11.5 Fate Therapeutics, Inc

11.5.1 Fate Therapeutics, Inc Company Information

11.5.2 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered

11.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 Fate Therapeutics, Inc Main Business Overview

11.5.5 Fate Therapeutics, Inc Latest Developments

11.6 Pluricell Biotech

11.6.1 Pluricell Biotech Company Information

11.6.2 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Offered

11.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 Pluricell Biotech Main Business Overview

11.6.5 Pluricell Biotech Latest Developments

11.7 Cell Inspire Biotechnology

11.7.1 Cell Inspire Biotechnology Company Information

11.7.2 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Offered

11.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 Cell Inspire Biotechnology Main Business Overview

11.7.5 Cell Inspire Biotechnology Latest Developments

11.8 ReproCELL

11.8.1 ReproCELL Company Information

11.8.2 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Offered

11.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 ReproCELL Main Business Overview

11.8.5 ReproCELL Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Human iPSCs

Table 3. Major Players of Mouse iPSCs

Table 4. Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Type (2016-2021) & ($ Millions)

Table 5. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) & ($ Millions)

Table 6. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2016-2021)

Table 7. Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 8. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) & ($ Millions)

Table 9. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2016-2021)

Table 10. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Players (2019-2021E) & ($ Millions)

Table 11. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Players (2019-2021E)

Table 12. Global Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Products Offered

Table 13. Induced Pluripotent Stem Cells (iPSCs) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Regions 2016-2021 & ($ Millions)

Table 17. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Regions 2016-2021

Table 18. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021) & ($ Millions)

Table 19. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country (2016-2021)

Table 20. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) & ($ Millions)

Table 21. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2016-2021)

Table 22. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) & ($ Millions)

Table 23. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2016-2021)

Table 24. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2016-2021) & ($ Millions)

Table 25. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2016-2021)

Table 26. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) & ($ Millions)

Table 27. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2016-2021)

Table 28. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) & ($ Millions)

Table 29. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2016-2021)

Table 30. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2016-2021) & ($ Millions)

Table 31. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country (2016-2021)

Table 32. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) & ($ Millions)

Table 33. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2016-2021)

Table 34. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) & ($ Millions)

Table 35. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2016-2021)

Table 36. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2016-2021) & ($ Millions)

Table 37. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2016-2021)

Table 38. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2016-2021) & ($ Millions)

Table 39. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2016-2021)

Table 40. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2016-2021) & ($ Millions)

Table 41. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2016-2021)

Table 42. Key and Potential Regions of Induced Pluripotent Stem Cells (iPSCs)

Table 43. Key Application and Potential Industries of Induced Pluripotent Stem Cells (iPSCs)

Table 44. Key Challenges of Induced Pluripotent Stem Cells (iPSCs)

Table 45. Key Trends of Induced Pluripotent Stem Cells (iPSCs)

Table 46. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 47. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Regions

Table 48. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 49. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Type (2021-2026)

Table 50. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 51. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Application (2021-2026)

Table 52. Fujifilm Holding Corporation (CDI) Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors

Table 53. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Offered

Table 54. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 55. Fujifilm Holding Corporation (CDI) Main Business

Table 56. Fujifilm Holding Corporation (CDI) Latest Developments

Table 57. Ncardia Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors

Table 58. Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Offered

Table 59. Ncardia Main Business

Table 60. Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 61. Ncardia Latest Developments

Table 62. Sumitomo Dainippon Pharma Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors

Table 63. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Offered

Table 64. Sumitomo Dainippon Pharma Main Business

Table 65. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 66. Sumitomo Dainippon Pharma Latest Developments

Table 67. Astellas Pharma Inc Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors

Table 68. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered

Table 69. Astellas Pharma Inc Main Business

Table 70. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 71. Astellas Pharma Inc Latest Developments

Table 72. Fate Therapeutics, Inc Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors

Table 73. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Offered

Table 74. Fate Therapeutics, Inc Main Business

Table 75. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 76. Fate Therapeutics, Inc Latest Developments

Table 77. Pluricell Biotech Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors

Table 78. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Offered

Table 79. Pluricell Biotech Main Business

Table 80. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 81. Pluricell Biotech Latest Developments

Table 82. Cell Inspire Biotechnology Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors

Table 83. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Offered

Table 84. Cell Inspire Biotechnology Main Business

Table 85. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 86. Cell Inspire Biotechnology Latest Developments

Table 87. ReproCELL Details, Company Type, Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors

Table 88. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Offered

Table 89. ReproCELL Main Business

Table 90. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 91. ReproCELL Latest Developments

List of Figures

Figure 1. Induced Pluripotent Stem Cells (iPSCs) Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2016-2021)

Figure 7. Induced Pluripotent Stem Cells (iPSCs) in Academic Research

Figure 8. Global Induced Pluripotent Stem Cells (iPSCs) Market: Academic Research (2016-2021) & ($ Millions)

Figure 9. Induced Pluripotent Stem Cells (iPSCs) in Drug Development and Discovery

Figure 10. Global Induced Pluripotent Stem Cells (iPSCs) Market: Drug Development and Discovery (2016-2021) & ($ Millions)

Figure 11. Induced Pluripotent Stem Cells (iPSCs) in Toxicity Screening

Figure 12. Global Induced Pluripotent Stem Cells (iPSCs) Market: Toxicity Screening (2016-2021) & ($ Millions)

Figure 13. Induced Pluripotent Stem Cells (iPSCs) in Regenerative Medicine

Figure 14. Global Induced Pluripotent Stem Cells (iPSCs) Market: Regenerative Medicine (2016-2021) & ($ Millions)

Figure 15. Induced Pluripotent Stem Cells (iPSCs) in Others

Figure 16. Global Induced Pluripotent Stem Cells (iPSCs) Market: Others (2016-2021) & ($ Millions)

Figure 17. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2020

Figure 18. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Player in 2020

Figure 19. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Regions (2016-2021)

Figure 20. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size 2016-2021 ($ Millions)

Figure 21. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size 2016-2021 ($ Millions)

Figure 22. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size 2016-2021 ($ Millions)

Figure 23. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size 2016-2021 ($ Millions)

Figure 24. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country in 2020

Figure 25. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type in 2020

Figure 26. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2020

Figure 27. United States Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions)

Figure 28. Canada Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions)

Figure 29. Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions)

Figure 30. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Regions in 2020

Figure 31. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type in 2020

Figure 32. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2020

Figure 33. China Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions)

Figure 34. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions)

Figure 35. Korea Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions)

Figure 36. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions)

Figure 37. India Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions)

Figure 38. Australia Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions)

Figure 39. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Countries in 2020

Figure 40. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type in 2020

Figure 41. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2020

Figure 42. Germany Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions)

Figure 43. France Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions)

Figure 44. UK Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions)

Figure 45. Italy Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions)

Figure 46. Russia Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions)

Figure 47. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region in 2020

Figure 48. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type in 2020

Figure 49. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2020

Figure 50. Egypt Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions)

Figure 51. South Africa Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions)

Figure 52. Israel Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions)

Figure 53. Turkey Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions)

Figure 54. GCC Countries Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2016-2021 ($ Millions)

Figure 55. Americas Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 56. APAC Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 57. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 58. Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 59. United States Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 60. Canada Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 61. Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 62. Brazil Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 63. China Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 64. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 65. Korea Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 66. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 67. India Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 68. Australia Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 69. Germany Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 70. France Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 71. UK Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 72. Italy Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 73. Russia Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 74. Spain Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 75. Egypt Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 76. South Africa Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 77. Israel Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 78. Turkey Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)

Figure 79. GCC Countries Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ Millions)